Cochlear Implant for Single-Sided Deafness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if cochlear implants, a type of auditory prosthesis, are a safe and effective treatment for infants and toddlers with single-sided deafness. Researchers will monitor the auditory development of children who receive the implant until they turn five. The study will compare these children to those with normal hearing and those with single-sided deafness who do not receive implants. Children with single-sided deafness, who have not benefited from traditional hearing aids and have hearing loss in one ear, could be suitable candidates for this trial.
As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research that could enhance treatment options for young children with single-sided deafness.
Do I need to stop my child's current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications. It's best to discuss this with the trial coordinators or your child's doctor.
What prior data suggests that cochlear implants are safe for infants and toddlers with single-sided deafness?
Research shows that cochlear implants are generally safe and well-tolerated. Studies on adults with hearing loss in one ear have found that these implants can improve hearing without causing serious side effects. While most research focuses on adults, some studies on children with hearing loss in one ear show mixed results regarding their benefit from the implants. However, these studies have reported no major severe problems linked to the implants.
It's important to know that receiving a cochlear implant involves surgery, which carries the usual risks. Overall, cochlear implants have been used for many years to help people hear better, suggesting their safety. If the implant is approved for other conditions, it usually means it has passed safety tests for those uses.12345Why are researchers excited about this trial?
Researchers are excited about the use of cochlear implants for single-sided deafness because this approach could transform how we address the condition. Unlike traditional treatments like hearing aids or bone-anchored hearing systems, which amplify sound or transmit it through bone conduction, cochlear implants directly stimulate the auditory nerve. This direct stimulation may offer clearer sound perception and improved spatial hearing, potentially leading to better speech understanding in noisy environments. This innovative approach could provide a significant quality-of-life improvement for individuals with single-sided deafness.
What evidence suggests that cochlear implants are effective for single-sided deafness in infants and toddlers?
Research shows that cochlear implants can help treat hearing loss in one ear. Studies have found that adults with hearing loss in one ear often hear speech better and can locate sounds more accurately after receiving an implant. In children, early cochlear implantation has been linked to improved hearing and language skills. Although most research focuses on older patients, these findings suggest potential benefits for infants and toddlers as well. This trial will evaluate the effectiveness of cochlear implants in children with single-sided deafness. Overall, cochlear implants are considered a promising option for hearing loss in one ear.23567
Who Is on the Research Team?
Lisa Park, AuD
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for infants and toddlers aged 7 months to under 3 years with severe-to-profound hearing loss in one ear, which isn't getting better with hearing aids. They should be generally healthy, have normal development and cognition, and their families must speak English at home. Kids can't join if they have certain inner ear abnormalities, lack of cochlear nerve, or conditions that make surgery risky.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cochlear implantation and receive programming of the device
Follow-up
Participants are monitored for safety and effectiveness, including auditory development and device-related adverse events
Testing and Evaluation
Participants undergo various auditory and cognitive tests, including localization, hearing in noise, and word recognition testing
What Are the Treatments Tested in This Trial?
Interventions
- Cochlear Implant
Cochlear Implant is already approved in United States, European Union for the following indications:
- Single-sided deafness (SSD) in children aged 5 years and older
- Severe to profound sensorineural hearing loss in both ears
- Severe to profound sensorineural hearing loss in both ears
- Single-sided deafness (SSD) in children and adults
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Med-El Corporation
Industry Sponsor